Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2009

Jun 29, 2009

65122_rns_2009-06-29_4a4e3583-127e-4a36-957c-a1584ccade28.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: DR. RICHARD HAMMEL 11[th] June 2008 Date of Last Notice:

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest Direct or Indirect Interest Direct (Unlisted Options PRRAY) Direct (Unlisted Options PRRAY) Direct (Unlisted Options PRRAY) Direct (Unlisted Options PRRAY)
Nature of Indirect Interest(including registered holder) Note:Provide details of the circumstances giving rise to the relevantinterest.
Date of change 26thFebruary 2009 (expiry of options)
No. of securities held prior to change
Shares Options
Direct - 500,000
Indirect - 10,000,000
Total - 10,500,000
Class Unlisted options PRRAY (exercisable at$0.20 on or before 26th February 2009)
Number Acquired Options---
Shares Options
Direct - -
Indirect - -
Total - -
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number Disposed Shares Options
Direct - 500,000
Indirect - -
Total - 500,000
Value/ConsiderationNote:If consideration is non-cash, provide details and estimated valuation Nil
No. of Securities Held After Change Options-10,000,00010,000,000
Shares Options
Direct - -
Indirect - 10,000,000
Total - 10,000,000
Nature of ChangeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back Expiry of unlisted PRRAY options

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

part.
Detail of Contract
Nature of Interest
Name of Registered Holder(if issued securities)
Date of Change
No. and Class of Securities toWhich Interest Related Prior toChangeNote:Details are only required for a contract in relation towhich the interest has changed
Interest Acquired
Interest Disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest After Change

==> picture [23 x 14] intentionally omitted <==

30.06.2009

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002